About Nanoscope Therapeutics

About company

Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. We utilize ambient light-sensitive molecules to re-sensitize the retina toward a low light level. Our light-assisted gene therapy is highly targeted to geographic atrophies without perturbing the intact retina circuitry. Our team is highly experienced in Ophthalmology product development and clinical translation of innovative research. Our pipeline includes light-based retinal regeneration therapy and light-based cortical prosthetics for vision restoration.